Get started
Author

Wolfgang Wick

Observed name: W. Wick
Observed institutions: F. Hoffmann-La Roche AG, The University of Texas MD Anderson Cancer Center, Harvard University, Innsbruck Medical University, German Cancer Research Center, Genentech, Washington University in St. Louis, Heidelberg University, University Hospital Heidelberg, University Hospital Zurich, Center for Neuro-Oncology, National Center for Tumor Diseases, Dana-Farber Cancer Institute, Hertie Institute for Clinical Brain Research, Deutsches Konsortium für Translationale Krebsforschung, University of Tübingen, Otto-von-Guericke-Universität Magdeburg
ORCID: 0000-0001-5681-7771
Observed ORCID: 0000-0001-5681-7771
OpenAlex ID: A5078857973
One week on/one week off: A novel active regimen of temozolomide for recurrent glioblastoma
2004 · W. Wick, J. P. Steinbach, et al. · Neurology · 155
Pathway inhibition: emerging molecular targets for treating glioblastoma
2011 · W. Wick, M. Weller, et al. · Neuro-Oncology · 152
Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials
2013 · K. Han, M. Ren, et al. · Neuro-Oncology · 149
PDF
Molecular determinants of glioma cell migration and invasion
2001 · Christine Wild-Bode, Michael Weller, et al. · Journal of neurosurgery · 133
Pseudoprogression in patients with glioblastoma: clinical relevance despite low incidence
2014 · A. Radbruch, J. Fladt, et al. · Neuro-Oncology · 119
N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-? release and reduces migration and invasiveness of human malignant glioma cells
2001 · Michael Platten, Christine Wild-Bode, et al. · International Journal of Cancer · 91
Ezrin-Dependent Promotion of Glioma Cell Clonogenicity, Motility, and Invasion Mediated by BCL-2 and Transforming Growth Factor-β2
2001 · Wolfgang Wick, Cornelia Grimmel, et al. · Journal of Neuroscience · 90
PDF
Improved Brain Tumor Classification by Sodium MR Imaging: Prediction ofIDHMutation Status and Tumor Progression
2015 · A. Biller, S. Badde, et al. · American Journal of Neuroradiology · 75
PDF
The mTOR signaling pathway as a treatment target for intracranial neoplasms
2014 · D. Pachow, W. Wick, et al. · Neuro-Oncology · 58
APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo
2010 · G. Eisele, P. Roth, et al. · Neuro-Oncology · 57
PDF
T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vessels
2024 · Julia M. Messmer, Calvin Thommek, et al. · Immunity · 26
Neuroradiological Response Criteria for High-grade Gliomas
2011 · K. Lutz, A. Radbruch, et al. · Clinical Neuroradiology · 25
Arterial hypertension and bevacizumab treatment in glioblastoma: no correlation with clinical outcome
2009 · A. Wick, N. Schäfer, et al. · Journal of Neuro-Oncology · 22
Trabedersen to target transforming growth factor- : when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142)
2011 · W. Wick, M. Weller · Neuro-Oncology · 19
PDF
Painful neuropathy due to intraneural leukemic spread in a patient with acute myeloid leukemia
2007 · M. Platten, C. A. Opitz, et al. · Neurology · 16
PDF
Assessment of Tumor Cell Invasion and Radiotherapy Response in Experimental Glioma by Magnetic Resonance Elastography
2024 · Hannah Fels‐Palesandro, Sophie Heuer, et al. · Journal of Magnetic Resonance Imaging · 15
Treosulfan Chemotherapy for Recurrent Malignant Glioma
2000 · Friederike Schmidt, Wolfgang Wick, et al. · Journal of Neuro-Oncology · 11
Combined peritumoral radiomics and clinical features predict 12-month progression free survival in glioblastoma
2025 · Yeong Chul Yun, Johann M. E. Jende, et al. · Journal of Neuro-Oncology · 10
OS11.5 ACT IV: An international, double-blind, phase 3 trial of rindopepimut in newly diagnosed, EGFRvIII-expressing glioblastoma
2017 · M. Weller, N. A. Butowski, et al. · Neuro-Oncology · 10
PDF
IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread
2025 · Felix Hinz, Dennis Friedel, et al. · Acta Neuropathologica · 9
PDF
Differentiating Glioma Recurrence and Pseudoprogression by APTw CEST MRI
2024 · Kianush Karimian-Jazi, Noah Enbergs, et al. · Investigative Radiology · 9
Histopathological and molecular characteristics of IDH-wildtype glioblastoma without contrast enhancement: Implications for clinical outcomes
2025 · Martha Foltyn-Dumitru, Rouzbeh Banan, et al. · Neuro-Oncology · 8
Amide proton transfer weighted MRI measurements yield consistent and repeatable results in patients with gliomas: a prospective test-retest study
2024 · Irada Pflüger, Aditya Rastogi, et al. · European Radiology · 8
Utilization of universal-targeting mSA2 CAR-T cells for the treatment of glioblastoma
2025 · Alexandros Kourtesakis, Eileen Bailey, et al. · OncoImmunology · 6
Anaplastische Gliome: Neuropathologie, molekulare Diagnostik und aktuelle Studienkonzepte
2010 · W. Wick, M. Weller · Der Nervenarzt · 6
PDF
Works count: 59
Citation count: 1,314
H-index: 15
I10-index: 19
Year
Topic
Type